Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter

Your Filters

Publisher : w.b. saunders Subject : covid-19 Subject : emotional engagement Subject : influenza, human
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: The Journal of infection [J Infect] 2023 Sep; Vol. 87 (3), pp. 230-241. Date of Electronic Publication: 2023 Jun 17.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population.

  • Authors : Ng RWY; Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China.; Sze RKH

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: The Journal of infection [J Infect] 2023 Aug; Vol. 87 (2), pp. 136-143. Date of Electronic Publication: 2023 May 26.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Viral Vaccines*; Female

  • Source: The Journal of infection [J Infect] 2023 Jul; Vol. 87 (1), pp. 18-26. Date of Electronic Publication: 2023 Apr 20.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

  • Source: The Journal of infection [J Infect] 2023 Jun; Vol. 86 (6), pp. 574-583. Date of Electronic Publication: 2023 Apr 06.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).

  • Authors : Li X; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Tuberculosis*; Humans

  • Source: The Journal of infection [J Infect] 2023 Mar; Vol. 86 (3), pp. 256-308. Date of Electronic Publication: 2022 Dec 17.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study.

  • Authors : Patel NJ; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Rheumatology Associates, 55 Fruit Street, Boston, MA, 02114, USA; Harvard Medical School, Boston, MA, USA.

Subjects: Breakthrough Infections*/Breakthrough Infections*/Breakthrough Infections*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2023 Feb; Vol. 58, pp. 152108. Date of Electronic Publication: 2022 Oct 26.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Report

Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.

  • Authors : Wan EYF; Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Diabetes Mellitus*

  • Source: The Journal of infection [J Infect] 2022 Nov; Vol. 85 (5), pp. e140-e144. Date of Electronic Publication: 2022 Aug 17.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination.

  • Authors : Noh JY; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, South Korea.

Subjects: Antibodies, Neutralizing* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Antibodies, Viral

  • Source: The Journal of infection [J Infect] 2022 Nov; Vol. 85 (5), pp. 573-607. Date of Electronic Publication: 2022 Jul 31.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2.

  • Authors : Gidari A; Department of Medicine and Surgery, Clinic of Infectious Diseases, 'Santa Maria della Misericordia' Hospital, University of Perugia, Piazzale Lucio Severi 1, Perugia 06132, Italy. Electronic address: .; Schiaroli E

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*; Antibodies, Neutralizing SARS-CoV-2 variants

  • Source: The Journal of infection [J Infect] 2022 Nov; Vol. 85 (5), pp. e125-e126. Date of Electronic Publication: 2022 Aug 27.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.

  • Authors : Niyomnaitham S; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand; Siriraj Institute of Clinical Research (SICRES), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Subjects: COVID-19* ; SARS-CoV-2*; Adult SARS-CoV-2 variants

  • Source: The Journal of infection [J Infect] 2022 Oct; Vol. 85 (4), pp. 436-480. Date of Electronic Publication: 2022 Jun 18.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×